Sheffield risk and treatment table for cholesterol lowering in prevention of coronary heart disease [3]

Lancet

Volumn 347, Issue 8999, 1996, Pages 466-469

  James, M A ^a   Wierzbicki, A S ^a   Reynolds, T M ^a   Haq, I U ^a   Jackson, P R ^a   Yeo, W W ^a   Ramsay, L E ^a  

^a TAUNTON AND SOMERSET HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPOCHOLESTEROLEMIC AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PRAVASTATIN; SIMVASTATIN;

ALGORITHM; ATHEROMA; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DATA ANALYSIS; DIET; DRUG EFFICACY; HUMAN; ISCHEMIC HEART DISEASE; LETTER; META ANALYSIS; MORBIDITY; MORTALITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK; ADULT; BLOOD; FEMALE; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; NOTE; PRIMARY PREVENTION; RISK FACTOR; AGED;

ADULT; CHOLESTEROL; CORONARY DISEASE; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; PRIMARY PREVENTION; RISK FACTORS; AGED; ALGORITHMS;

EID: 0030063704     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)90043-4     Document Type: Letter

References (22)

1. Iu Haq Pr Jackson Ww Yeo Le Ramsay Sheffield risk and treatment table for cholesterol lowering for primary prevention of coronary heart disease Lancet 346 1995 1467 1471
2. Scandinavian Simvastatin Survival Study Group Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Lancet 344 1994 1383 1389
3. Iu Haq Pr Jackson Ww Yeo Le Ramsay Sheffield risk and treatment table for cholesterol lowering for primary prevention of coronary heart disease Lancet 346 1995 1467 1471
4. R. Jackson R. Beaglehole Evidence-based management of dyslipidaemia Lancet 346 1995 1440 1441
5. Scandinavian Simvastatin Survival Group Baseline serum cholesterol and treatment effect in the Scandinavian Simvastatin Survival Study Lancet 345 1995 1274 1275
6. J. Shepherd Sm Cobbe I. Ford Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia N Engl J Med 333 1995 1301 1307
7. Km Anderson Pm Odell Pwf Wilson Wb Kannel Cardiovascular disease risk profiles Am Heart J 121 1991 293 298
8. Iu Haq Pr Jackson Ww Yeo Le Ramsay Sheffield risk and treatment table for cholesterol lowering for primary prevention of coronary heart disease Lancet 346 1995 1467 1471
9. R. Jackson R. Beaglehole Evidence-based management of dyslipidaemia Lancet 346 1995 1440 1441
10. GISSI-Prevenzione Investigators Protocollo dello studio GISSI-Prevenzione: Studio di intervento preventivo sulle componenti aterosclerotica e trombotica del rischio post-infarto G Ital Cardiol 23 1993 1053 1061
11. R. Marchioli, Rm Marfisi, F. Carinci, et al., Meta-analysis, clinical trials, and transferability of research results into clinical practice: the case of cholesterol-lowering interventions in secondary prevention of coronary heart disease, Arch Intern Med ((in press)).
12. J. Shepherd Sm Cobbe I. Ford Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia N Engl J Med 333 1995 1301 1307
13. Iu Haq Pr Jackson Ww Yeo Le Ramsay Sheffield risk and treatment table for cholesterol lowering for primary prevention of coronary heart disease Lancet 346 1995 1467 1471
14. Scandinavian Simvastatin Survival Study Group Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Lancet 344 1994 1383 1389
15. Km Anderson Pm Odell Pwf Wilson Wb Kanell Cardiovascular disease risk profile Am Heart J 121 1991 293 298
16. J. Shepherd Sm Cobbe I. Ford Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia N Engl J Med 333 1995 1301 1307
17. A. Simon P. Giral J. Levenson Extracoronary atherosclerosis plaque at multiple sites and total coronary calcification deposits in asymptomatic men: association with coronary risk profile Circulation 92 1995 1414 1421
18. Scandinavian Simvastatin Survival Study Group Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Lancet 344 1994 1383 1389
19. Mr Law Nj Wald Sg Thompson By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? BMJ 308 1994 367 372
20. K. Pyörälä G. De Backer I. Graham P. Poole-Wilson D. Wood Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension Eur Heart J 15 1994 1300 1331
21. Wmm Verschuren D. Kromhout Total cholesterol concentration and mortality at a relatively young age: do men and women differ? BMJ 311 1995 779 783
22. J. Shepherd Sm Cobbe I. Ford West of Scotland Coronary Prevention Study Group Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia N Engl J Med 333 1995 1301 1307